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Aim: To study the effect of strict prolonged fasting on lipid profile, serum leptin, and 
  high-sensitivity C-reactive protein (hs-CRP) in patients with different stable cardiac illnesses 
and look for associated new cardiac events and any correlation between entire variables.
Methods: A total of 56 patients of different stable cardiac illnesses were followed in our 
  cardiology outpatient for 3 months. Data concerning their ability to fast were collected: 
New York Heart Association class of congestive cardiac failure, angina class, previous   myocardial 
infarction, previous coronary artery bypass graft, percutaneous coronary intervention,   severity of 
valvular lesion, metallic prosthetic valve, and traditional risk factors (diabetes mellitus, insulin 
requirement, hypertension, hypercholesterolemia, smoking habit, and obesity). Detailed   clinical 
examination and electrocardiography were performed in all patients in three   consecutive visits 
before, during, and after Ramadan. Echocardiographic and angiographic findings and   medication 
plans were collected from patient records. Lipid profile, serum leptin, and hs-CRP were assessed 
before, during, and after Ramadan.
Results: All patients fasted during Ramadan: 80.4% were male, 67.9% were aged .50 years, 
71.4% had no change in their symptoms during fasting while 28.6% felt better. No patient has 
deteriorated. 91.1% of the patients were compliant with medicine during Ramadan, 73.2% 
after. 89.3% were compliant with diet during Ramadan with no significant change in body 
weight in the follow-up period. No cardiac or noncardiac morbidity or mortality was reported. 
  High-density lipoprotein-cholesterol (HDL-C) decreased significantly during compared to before 
fasting (P = 0.012). Low-density lipoprotein-cholesterol (LDL-C) significantly increased dur-
ing compared to before fasting (P = 0.022). No statistically significant changes were observed 
in total cholesterol (TC),   triglycerides (TG), serum leptin, or hs-CRP. Significant correlation 
was observed between TC and hs-CRP during fasting (P = 0.036), but not with TG, LDL-C, or 
HDL-C (P . 0.05).   Neither of these correlated with serum leptin (P . 0.05), but significant 
correlation was observed between hs-CRP and serum leptin (P , 0.05).
Conclusion: Ramadan fasting in stable cardiac patients has no effect on their clinical status, 
serum leptin, or hs-CRP, but results in decrease in HDL-C, increase in LDL-C, with significant 
correlation between TC and hs-CRP during Ramadan, but not with TG, LDL-C, or HDL-C, and 
with significant correlation between hs-CRP and serum leptin before, during, and after fasting.
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Introduction
The Islamic fast during the month of Ramadan, during which a whole month is 
  dedicated to fasting is particular to Islam, and is strictly observed by millions of 
Muslims worldwide. Since more than a billion people worldwide follow Islam, it is 
assumed that hundreds of millions of people observe the Ramadan fast each year.1,2Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
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From a physiological standpoint, Islamic fasting provides 
a unique fasting model. It is distinct from regular voluntary 
or experimental fasting by the fact that the observant of the 
fast does not drink during fasting which may reach more 
than 12 hours. Therefore, one may assume that physiological 
changes occurring during Islamic fasting would be different 
from those noted during an experimental fast.3,4 Studies on 
the effect of Ramadan fasting on blood lipids have produced 
variable results.5–9 Among patients with known stable coro-
nary disease, a correlation between serum C-reactive protein 
(CRP) and acute coronary events has been demonstrated in 
some studies.10–12 In addition, high-sensitivity CRP (hs-CRP) 
has been shown in some studies to be affected by fasting, 
weight loss, and with postchallenge glycemia than with fast-
ing glucose levels in nondiabetic subjects.13–16
More recently, leptin was found to have multiple roles 
in the cardiovascular system as a vasoactive substance, in 
coronary artery vasoreactivity, regulation of myocardial 
blood flow,17 may also have a prothrombotic effect,18 and 
may increase with acute myocardial infarction (AMI).19 
Serum leptin was independently associated with serum 
CRP, suggesting that body fat may be the most significant 
predictor of CRP.20
The most frequently asked question by cardiac patients 
to their cardiologist is whether Ramadan fasting has any 
adverse effect on their cardiac status. The answer has not 
yet been clarified. We have previously reported alteration 
in the time of onset of cardiac events during Ramadan fast-
ing when compared with the rest of the year, where there 
was a peak of cardiac events during the “breaking of fast” 
period.21 On the other hand, the prevalence of hospitaliza-
tion for acute coronary syndrome22,23 and heart failure3 were 
not different from the remaining months of the year. The 
current study complements our previous reports in studying 
the impact of Ramadan fasting on serum leptin, CRP, and 
lipid profile among ambulatory patients with stable coronary 
artery disease.
Our aim was to study the effect of strict and prolonged 
Ramadan fasting on lipid profile, serum leptin, and hs-CRP 
in stable cardiac patients and check whether there were any 
new adverse cardiac events and whether there is any correla-
tion between these entire variables.
Subjects and methods
study design
This prospective study was conducted at the cardiol-
ogy outpatient department of Hamad General Hospital. 
  Different classes of stable cardiac patients were followed for 
3 months with three consecutive visits before, during, and 
after   Ramadan. The study was approved by the hospital 
Institutional Review Board and informed consent was 
obtained from all patients.
Baseline clinical characteristics include age, gender, 
cardiovascular risk factors, and primary as well as sec-
ondary cardiovascular diagnoses were recorded. Patients 
with angina pectoris were subclassified according to the 
Canadian Cardiovascular Society classification of effort 
angina (I to IV). In addition, patients with congestive heart 
failure were subclassified according to the New York Heart 
Association classification (I to IV). Patients were carefully 
examined for the presence of clinical signs of heart failure 
and the findings were recorded. Their body weight and 
height were recorded and subsequently body mass index 
(BMI) was calculated. Electrocardiographic, angiographic, 
and echocardiographic findings were recorded as well as 
previous revascularization and cardiac surgical procedures. 
Patients subsequently were evaluated during the middle of 
Ramadan to see whether they were able to continue fasting 
or if they were hospitalized for a cardiac-related reason or 
developed cardiac events.23
Definitions
Congestive heart failure (CHF) was defined using the 
Framingham Heart Study criteria and acute coronary syn-
dromes including AMI and unstable angina were defined 
according to World Health Organization guidelines as 
reported previously.3 The presence of diabetes   mellitus 
and hypertension were determined by the patient’s 
previous or current medical records of a documented 
diagnosis of diabetes mellitus and hypertension that had 
been treated with medications. The presence of hyperlipi-
demia was determined by the demonstration of a fasting 
cholesterol .5.2 mmol/L in the patient’s medical record, 
or any history of treatment for hyperlipidemia by patient’s 
physician. The study was approved and sponsored by 
Hamad Hospital research committee.
Biochemical and immunological analyses
Fasting blood samples were collected from each patient in the 
middle of Ramadan between 9 am and 11 am a month before 
and a month after at the same time as the nonfasting sample. 
All samples were separated and analyzed immediately with 
exception of serum leptin. Aliquots for serum leptin were 
stored at −80°C until the collection was completed.
Leptin concentrations were measured with ELISA. Linco 
Research, Inc (St. Charles, MO) supplied the reagents. Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
9
Ramadan fasting in stable cardiac patients
The measuring range was 0.5–100 ng/mL. According to the 
manufacturer, the assay has high correlation with radioim-
munoassay for human leptin (r = 0967), its lower detection 
limit was 0.5 ng/mL and the variation in plasma leptin 
concentrations of 3.2 ng/mL and 8.18 ng/mL were 5% and 
3.0%, respectively.24
Total cholesterol (TC), triglycerides (TG), and HDL-
cholesterol (HDL-C) was determined enzymatically by 
Hitachi 917 (Roche, Mannheim, Germany). LDL-cholesterol 
(LDL-C) was estimated among those with TG concentrations 
,4.5 mmol/L as TC-HDL-C-TG/2.2.25 Those with TG .4.5 
were measured directly by reagents from the same manufac-
turer.26 Between-run imprecision (CVs) for TC, TG, and mea-
sured LDL-C were 3.0%, 4.0%, and 2.0%, respectively.
Normal fasting ranges for serum leptin are directly 
correlated with the degree of adiposity, with BMI range 
18–25 serum leptin levels for men (3.8 ± 1.8 µg/L), and for 
women (7.4 ± 3.7 µg/L). Serum leptin levels rise approxi-
mately 2.5 times faster in women per unit of BMI as com-
pared with men. There was a diurnal rhythm of serum leptin 
concentrations, the values being 20% to 40% higher in the 
middle of the night as compared with daytime.27,28 The peak 
shifts are in parallel with shifts in the timing of meals.29
High-sensitivity C-reactive protein test
Quantitative determination of human CRP in serum or plasma 
was by rate turbidimetry using IMMAGE® CRPH reagent 
(Beckman Coutler, Fullerton, CA) which is based on the 
highly sensitive near-infrared particle immunoassay rate 
methodology. An anti-CRP antibody-coated particle binds to 
CRP in the patient sample, which results in the formation of 
insoluble aggregates that cause turbidity. The rate of aggre-
gate formation is directly proportional to the concentration of 
CRP in the sample. The IMMAGE immunochemistry system 
will automatically calculate results. The analytic range of 
the CRPH test is designed to detect C-reactive protein con-
centrations using an initial undiluted (neat) serum sample. 
The Beckman Coulter analytical range is from an initial 
0.02 to 6.0 mg/dL, and extended 0.02 to 144 mg/dL. The 
reference interval is ,0.744 mg/dL. The reference interval 
used a population of 615 apparently healthy, nonsmoking, 
aged $18 years, male and female adults from a southern 
California blood bank (as we did not establish our specific 
reference intervals yet).30
statistical analysis
The data were analyzed by SPSS software (SPSS Inc, 
Chicago, IL).31 Data were expressed as mean and standard 
deviation (SD) unless otherwise stated. Student’s t-test was 
used to ascertain the significant difference between mean 
values of two continuous variables and was confirmed by 
nonparametric Mann-Whitney U test. Fisher’s exact and 
Chi square tests were performed to test for difference in 
proportions of categorical variables between two and more 
groups. The Pearson’s correlation coefficient and Spearman 
correlations were used to evaluate the strength association 
between two variables. P , 0.05 was considered as the cut-
off value for significance.
Results
Baseline clinical characteristics showed that 80.4% of patients 
were male and 19.6% were female: half were Qatari   nationals; 
67.9% were aged .50 years; 53.6% had well-controlled 
heart failure; 83.9% were in NYHA class I–II; 80.4% had 
stable angina pectoris; 17.9% had previous MI; 19.6% had 
previous CABG; 8.9% had previous PCI; 28.6% had mitral 
valve replacement; 10.7% had aortic valve replacement; 
35.7% had diabetes mellitus, 25% of which required insulin; 
41.1% had hypertension; 37.5% had hypercholesterolemia; 
and 7.1% were smokers. Sixteen patients (28.65%) have BMI 
,25, 48.2% were overweight,25–30 and 23.2% were obese. Sys-
tolic and diastolic blood pressures of the studied patients were 
(mean ± SD) 123.91 ± 8.67 and 80.44 ± 3.92, respectively.
ECG findings
Normal sinus rhythm was found in 85.7%, 1.8% had old 
MI, 8.9% had atrial fibrillation, and 3.6% had left bundle 
branch block.
Medication during fasting
Medications taken by patients during Ramadan fasting were: 
aspirin, 60.7%; warfarin, 26.8%; angiotensin-converting 
enzyme inhibitors, 41.1%; β-blockers, 55.4%; nitrate, 32.1%; 
calcium channel blockers, 19.6%; statins, 51.8%; nonsteroi-
dal anti-inflammatory drugs, 12.5%. Only 3.6% developed 
simple bacterial infections.
Echocardiographic findings
The mean ± SD of EF% of the studied patients was 54.75 ± 
14.05 and the mean ± SD right ventricular systolic pressure 
(RVSP) were 36.21 ± 11.29.
Angiographic findings
Angiography found that 10.7% had single vessel disease, 
1.8% had two-vessel disease while 19.6% had three-vessel 
disease (Table 1).Vascular Health and Risk Management 2012:8
Table  1  Baseline  clinical  characteristics,  biochemical  profile, 
therapy, and outcome n = 56
Variables n (%)
gender
  Male 45 (80.4)
  Female 11 (19.6)
nationality
  Qatari 28 (50.0)
  Non-Qatari 28 (50.0)
Age group
 # 50 18 (32.1)
 . 50 38 (67.9)
congestive heart failure
  Yes 30 (53.6)
  no 26 (46.4)
Clinical finding
  nYHA class i–ii 47 (83.9)
  Angina 45 (80.4)
  Previous Mi 10 (17.9)
  Previous cABg 11 (19.6)
  Previous Pci 5 (8.9)
  MVR 16 (28.6)
  AVR 6 (10.7)
Risk factors
  Diabetes mellitus 20 (35.7)
  insulin required 5 (8.9)
  Hypertension 23 (41.1)
  Hypercholesterolemia 21 (37.5)
  smoking 4 (7.1)
Baseline heart rate (Mean ± sD) 84.79 ± 10.77
BMi
  Acceptable (,25) 16 (28.6)
  Overweight (25–30) 27 (48.2)
  Obesity (.30) 13 (23.2)
Blood pressure
  systolic (Mean ± sD) 123.91 ± 8.67
  Diastolic (Mean ± sD) 80.44 ± 3.92
ecg
  nsR 48 (85.7)
  Old Mi 1 (1.8)
  Atrial fibrillation 5 (8.9)
  LBBB 2 (3.6)
Medication taken during fasting
  Aspirin 34 (60.7)
  Warfarin 15 (26.8)
  Ace inhibitors 23 (41.1)
 β -blockers 31 (55.4)
  nitrates 18 (32.1)
  calcium channel blockers 11 (19.6)
  statins 29 (51.8)
  nsAiD 7 (12.5)
infection 2 (3.6)
Echocardiographic findings
  eF% (Mean ± sD) 54.75 ± 14.05
  RVsP (Mean ± sD) 36.21 ± 11.29
Angiographic findings
  sVD 6 (10.7)
  2VD 1 (1.8)
  3VD 11 (19.6)
Abbreviations: ACE, angiotensin-converting enzyme; AVR, aortic valve replacement; 
BMi, body mass index; cABg, coronary artery bypass graft; eF, ejection fraction; 
MI, myocardial infarction; MVR, mitral valve replacement; NSAID, nonsteroidal anti-
inflammatory drug; NYHA, New  York Heart Association; PCI, percutaneous coronary 
intervention; RVsP, right ventricular systolic pressure; sD, standard deviation; sVD, 
single vessel disease; VD, vessel disease.
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clinical course during fasting
All patients fasted during Ramadan, 71.4% had no change 
in their symptoms during Ramadan, while 28.6% felt better 
during Ramadan. No patients deteriorated. 91.1% of the 
patients were compliant with medicine during Ramadan and 
73.2% after Ramadan, 89.3% were compliant with their diet 
during Ramadan. There was no significant change in body 
weight before, during, and after Ramadan with any cardiac 
or noncardiac morbidity or mortality (Table 2).
Lipid profile during Ramadan
No statistical significant changes were seen in TC 
(5.35 ± 0.99, 5.58 ± 0.99, 5.50 ± 0.9) and TG (5.50 ± 0.99, 
2.21 ± 1.56, 1.92 ± 1.09; P . 0.05) before, during, and 
after Ramadan, respectively. HDL-C decreased signifi-
cantly during Ramadan than before fasting (1.05 ± 0.25 vs 
1.12 ± 0.24; P = 0.012), respectively, but LDL-C significantly 
increased during fasting than before fasting (3.31 ± 0.97 vs 
3.59 ± 0.92; P = 0.022), respectively (Table 3). No signifi-
cant changes in serum hs-CRP were found before, during, 
and after fasting (0.90 ± 1.84, 0.57 ± 0.46, 0.81 ± 0.80; 
P . 0.05), respectively (Table 3). No significant changes 
in serum leptin were found before, during, and after fasting 
(12.25 ± 10.52, 12.71 ± 10.58, 10.86 ± 10.30, P . 0.05), 
respectively (Table 3).
Spearman correlations showed significant correlation 
between hs-CRP and serum leptin before, during and after 
Ramadan (P , 0.05). No significant correlation was found 
between TC, TG, HDL-C, and LDL-C (P . 0.05) (Table 4).
Spearman correlations showed no significant correlation 
between TC, TG, HDL-C, and LDL-C (P . 0.05). There 
is significant correlation between TC and hs-CRP during 
Ramadan (P = 0.036) (Table 5).
Table 2 Follow up during the study period (n = 56)
Variables During Ramadan After Ramadan
How does he/she feel?
  same as before
  Better than before
  Worse than before
 
40 (71.4)
16 (28.6)
–
 
–
–
–
Patient compliance with medicine
  Yes
  no
51 (91.1)
5 (8.9)
41 (73.2)
15 (26.8)
Patient compliance with diet
  Yes
  no
50 (89.3)
6 (10.7)
41 (73.2)
15 (26.8)
is patient fasting?
  Yes
  no
 
56 (100)
0 (0.0)
 
51 (91.1)
5 (8.9)
Body weight
  Mean ± sD
 
78.91 ± 14.89
 
79.00 ± 14.52
Abbreviation: sD, standard deviation.Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
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Table 3 Laboratory findings of patients before, during, and after Ramadan (N = 56)
Variables Before Ramadan During Ramadan After Ramadan
serum leptin 12.25 ± 10.52 12.71 ± 10.58 10.86 ± 10.30
Total serum cholesterol 5.35 ± 0.99 5.58 ± 0.99 5.50 ± 0.99
Triglyceride 2.06 ± 0.94 2.21 ± 1.56 1.92 ± 1.09
High-density lipoprotein-cholesterol 1.12 ± 0.24* 1.05 ± 0.25 1.08 ± 0.25
Low-density lipoprotein-cholesterol 3.31 ± 0.97** 3.59 ± 0.92 3.58 ± 0.93
hs-C-reactive protein 0.90 ± 1.84 0.57 ± 0.46 0.81 ± 0.80
Notes: *P = 0.012 for before Ramadan vs during Ramadan; **P = 0.022 for before Ramadan vs after Ramadan.
Table 4 Spearman correlations between leptin, total cholesterol, LDL-C, HDL-C, triglyceride, and CRP
Variables Before Ramadan During Ramadan After Ramadan
R 
P-value
R 
P-value
R 
P-value
Serum leptin (before Ramadan)
Total serum cholesterol 0.049 
0.791
0.007 
0.971
−0.008 
0.966
Triglyceride −0.015 
0.937
−0.042 
0.824
−0.148 
0.419
HDL-C 0.095 
0.606
0.128 
0.499
0.079 
0.666
LDL-C 0.035 
0.848
0.040 
0.834
−0.004 
0.984
hs-C-reactive protein 0.345* 
0.042
0.359* 
0.034
0.398* 
0.018
Serum leptin (during Ramadan)
Total serum cholesterol 0.017 
0.925
0.013 
0.944
0.002 
0.991
Triglyceride −0.037 
0.838
0.008 
0.966
−0.183 
0.307
HDL-C 0.062 
0.733
0.031 
0.868
−0.008 
0.963
LDL-C 0.015 
0.935
0.061 
0.745
0.035 
0.847
hs-C-reactive protein 0.234 
0.170
0.354* 
0.034
0.387* 
0.020
Serum leptin (after Ramadan)
Total serum cholesterol −0.081 
0.655
0.035 
0.852
−0.052 
0.772
Triglyceride −0.115 
0.526
−0.147 
0.429
−0.299 
0.091
HDL-C 0.082 
0.650
0.132 
0.479
0.091 
0.613
LDL-C −0.053 
0.770
0.010 
0.957
−0.014 
0.939
hs-C-reactive protein 0.254 
0.135
0.338* 
0.044
0.243 
0.153
Note: *P-value ,0.05.
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
Discussion
Despite the fact that more than a billion Muslims worldwide 
practice fasting during Ramadan, the data on outcome of patients 
with cardiac disease who were fasting during Ramadan is lack-
ing. Fasting in Ramadan may have negative effects on patients 
with cardiovascular disease. The fasting obligation that the 
daily calorie intake has to be taken in one or two meals instead 
of three to five is an effort. On the other hand, fasting may be 
protective; hunger has been associated with catecholamine 
inhibition (catecholamine surge has been implicated as a trig-
ger for acute coronary syndrome) and reduced venous return 
causes a decrease in the sympathetic tone, which leads to a fall Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
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in blood pressure, heart rate and cardiac output.2 Moreover, Perk 
and colleagues32 reported a reduced heart rate during Ramadan. 
This could be due to the inhibition of catecholamine production 
during hunger.32 To the best of our knowledge, this is the first 
study to comprehensively analyze clinical findings in correla-
tion with the serum leptin, which was found to have a role in 
acute coronary syndrome, and in correlation with hs-CRP, the 
well-known inflammatory marker.
In the current study, all patients of different functional 
classes were cardiac patients and they finished fasting during 
Ramadan without any reported cardiac or noncardiac event in 
spite of their different nationalities and thus different lifestyle 
and dietary habits. Nearly 90% of them were compliant with 
medication (most of the cardiac medications are single-dose 
medications) and diet.
Studies on the effect of Ramadan fasting on blood lipids have 
produced variable results. Serum cholesterol may decrease in the 
first days of fasting and rise to prefasting values. Some studies 
have reported raised concentrations of cholesterol, which may be 
related to weight loss during Ramadan fasting. However, others 
have found no change, or only decreased levels of cholesterol 
during fasting.5–9 The evidence that a marked increase in plasma 
HDL-C occurs after Ramadan fasting is promising.33–36 This is in 
contrast to our current study, which found a significant decrease 
in HDL-C and an increase in LDL-C with no reflection on overall 
clinical status probably because of its short duration. Changes 
in blood lipids seem to be variable and depend probably on the 
quality and quantity of food consumption and the degree of 
weight changes in the patient.
Leptin was found to have multiple roles in the cardiovas-
cular system as a vasoactive substance, in coronary artery 
vasoreactivity, in regulation of myocardial blood flow,17 
and it may have a prothrombotic effect.18 Leptin levels may 
increase with acute MI.19 In the current study, in spite of the 
impact of Ramadan fasting on the diurnal rhythm of eating 
and sleeping, mean serum leptin shows no change during 
fasting when compared with that before and after fasting. 
This can be explained by the compliance of cardiac patients 
with diet and caloric intake and with no change in body 
weight (89.3%).
Table 5 Spearman correlations between C-reactive protein, cholesterol, LDL, HDL, and triglycerides
Variables Before Ramadan During Ramadan After Ramadan
R 
P-value
R 
P-value
R 
P-value
hs-C-reactive protein (before Ramadan)
Total serum cholesterol −0.284 
0.109
0.120 
0.520
0.179 
0.319
Triglyceride 0.18 
0.921
0.192 
0.302
0.035 
0.846
HDL-C −0.124 
0.493
0.003 
0.987
0.059 
0.745
LDL-C −0.189 
0.292
−0.059 
0.751
0.110 
0.541
hs-C-reactive protein (during Ramadan)
Total serum cholesterol −0.366 
0.036
0.036* 
0.845
−0.022 
0.902
Triglyceride −0.079 
0.662
0.128 
0.494
−0.083 
0.646
HDL-C −0.083 
0.647
0.084 
0.652
0.105 
0.560
LDL-C −0.279 
0.115
0.131 
0.484
−0.039 
0.828
C-reactive protein (after Ramadan)
Total serum cholesterol −0.037 
0.839
0.039 
0.837
0.007 
0.971
Triglyceride 0.066 
0.714
0.232 
0.209
0.061 
0.736
HDL-C −0.219 
0.221
−0.234 
0.204
−0.239 
0.181
LDL-C 0.051 
0.780
0.000 
0.998
0.170 
0.345
Note: *P-value ,0.05.
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.Vascular Health and Risk Management 2012:8 submit your manuscript | www.dovepress.com
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In contradiction to other studies that show that serum 
leptin significantly increases by approximately 41%, the 
explanation for this difference is that the studies were con-
ducted on healthy female volunteers during Ramadan who 
show an increased energy intake as measured by kilocalories/
day, but with no change in body weight or BMI.37 The clinical 
follow-up of our patients with no clinical event reported was 
compatible with our previous Gulf multicenter study.23
The role of CRP in cardiac disease has been raised by 
many studies as an acute phase-reactant protein. Serum 
CRP is significantly associated with other cardiovascular 
risk   factors. The highest values of serum CRP have been 
observed in patients with the greatest number of cardiovas-
cular risk factors, which suggests that it may be a useful 
clinical marker for future cardiovascular events.38–41 Among 
patients with known stable coronary disease, a correlation 
between serum CRP and acute coronary events has been 
demonstrated in some studies.10–12 In the current study, 
hs-CRP serum levels continue to show the same levels 
before, during, and after Ramadan, which is compatible 
with clinical follow-up of stable cardiac patients during 
fasting Ramadan.
Previous studies have shown that CRP levels increase 
continuously across the spectrum of fasting glucose in non-
diabetics13,14 and that CRP is independently associated with 
fasting hyperinsulinemia in nondiabetic women.15 Other 
studies show that CRP levels are more strongly associated 
with postchallenge glycemia than with fasting glucose 
levels in nondiabetic subjects. This association is partially 
independent of body fat and insulin resistance.16 In the cur-
rent study, although 35.7% of patients were diabetic and 
8.9% required insulin, we did not observe any fluctuation 
in CRP during the follow-up period. Moreover studies have 
shown that in young, apparently healthy men, serum leptin, 
but not BMI, was independently associated with serum 
CRP, which suggests that the amount of body fat may be 
the most significant predictor of CRP.20 The current study 
also showed a significant correlation in hs-CRP and serum 
leptin before, during, and after Ramadan (P , 0.05). The 
importance of such a correlation needs to be explored in 
further studies.
Conclusion
Ramadan fasting, a prolonged, strict, and stressful event, 
in stable cardiac patients has no negative impact on clini-
cal status, serum leptin or hs-CRP, but results in decreased 
HDL-C and an increase in LDL-C. Significant correlations 
between hs-CRP and TC were found, but not in any other 
component lipid profile. A significant correlation was 
observed between hs-CRP and serum leptin. No significant 
correlation was found between serum leptin, TC, HDL-C, 
TG, or LDL-C.
study limitations
This study included a small number of stable cardiac patients 
with many risk factors for coronary artery disease. Unstable 
cardiac patients were excluded for ethical reasons. A larger 
sample is needed in future studies to confirm the current 
result. The results of this study complement our previous 
studies. It included patients from different cultures and edu-
cation levels. The answer to the cardiac patient’s question 
about fasting during Ramadan has been found. However, 
the decision to fast should be individualized to every patient 
according to their clinical status.
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